Word

CELLVERA

Status

Pending

Status Code

681

Status Date

Thursday, May 2, 2024

Serial Number

97317740

Mark Type

3

Filing Date

Thursday, March 17, 2022

Published for Opposition

Tuesday, June 4, 2024

Trademark Owner History

Cellvera Global Holdings LLC

Classifications

5 Drugs and pharmaceuticals in the form of solids, namely, capsules, medicated candy, tablets and liquids for the treatment of flu, viral infections including Covid-19, bacterial infections, diabetes, cancer, HIV, ulcers, high blood pressure, high cholesterol, seizures, epilepsy, muscle and joint pain; Pharmaceutical preparations, namely, pills for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores

42 Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals

The mark consists of the wording "CELLVERA" in a stylized font to the right of a circle consisting of small circles.
CELL VERA

Trademark Events

Mar 21, 2022

New Application Entered

Mar 22, 2022

New Application Office Supplied Data Entered

Mar 23, 2022

Notice Of Design Search Code E-Mailed

Jan 4, 2023

Assigned To Examiner

Jan 10, 2023

Non-Final Action Written

Jan 10, 2023

Non-Final Action E-Mailed

Jan 10, 2023

Notification Of Non-Final Action E-Mailed

May 31, 2023

Abandonment - Failure To Respond Or Late Response

Aug 31, 2023

Teas Petition To Revive Received

May 31, 2023

Abandonment Notice Mailed - Failure To Respond

May 31, 2023

Abandonment Notice E-Mailed - Failure To Respond

Aug 31, 2023

Petition To Revive-Granted

Aug 31, 2023

Notice Of Revival - E-Mailed

Aug 31, 2023

Teas Response To Office Action Received

Sep 1, 2023

Notice Of Revival - E-Mailed

Jan 22, 2024

Assigned To Lie

Jan 22, 2024

Correspondence Received In Law Office

Jan 22, 2024

Teas/Email Correspondence Entered

Jan 26, 2024

Final Refusal Written

Jan 26, 2024

Final Refusal E-Mailed

Jan 26, 2024

Notification Of Final Refusal Emailed

Apr 26, 2024

Correspondence Received In Law Office

Apr 26, 2024

Teas Request For Reconsideration Received

Apr 27, 2024

Teas/Email Correspondence Entered

Apr 29, 2024

Approved For Pub - Principal Register